Stocks Health care NRXP

NASDAQ · Health care

NRX Pharmaceuticals, Inc. (NRXP)

NRX Pharmaceuticals, Inc. brought in $3.6M of revenue over the twelve months to June 30, 2026. It posted a net loss of $23.5M. At June 30, 2026 it held $26.7M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.

What NRX Pharmaceuticals, Inc. does

NRX Pharmaceuticals, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker NRXP.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Where NRXP ranks in Health care

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What NRX Pharmaceuticals, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. September 16, 2026
   Other event 8-K
2. September 14, 2026
   Investor disclosure 8-K
3. August 17, 2026
   Quarterly results 8-K
4. August 14, 2026
   Quarterly report 10-Q · period to June 30, 2026
5. August 7, 2026
   Investor disclosure 8-K
6. July 22, 2026
   Other event 8-K
7. June 4, 2026
   Material agreement 8-K
8. June 3, 2026
   Securities offering prospectus 424B5
9. June 2, 2026
   Other event 8-K
10. June 2, 2026
    Securities offering prospectus 424B5

Recent insider filings (Forms 3, 4 and 144): 10, the latest on February 17, 2026. Insider transactions on SEC

Insider trades

What the people running NRX Pharmaceuticals, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

All insider filings on SEC.gov · Where insiders are buying across the market

All filings on SEC EDGAR

Questions about NRXP

What does NRX Pharmaceuticals, Inc. do?

NRX Pharmaceuticals, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker NRXP.

Is NRX Pharmaceuticals, Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $23.5M on revenue of $3.6M.

How much revenue does NRX Pharmaceuticals, Inc. make?

Over the twelve months to June 30, 2026 NRX Pharmaceuticals, Inc. reported revenue of $3.6M.

When did NRX Pharmaceuticals, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the other event from September 16, 2026.

Similar companies

Compare NRXP with

Compare NRXP with any company

Follow NRXP

Get an email when NRX Pharmaceuticals, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow NRXP: get an email when it files

Where the numbers come from

Financial figures are the values NRX Pharmaceuticals, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.